Synthesis and Antiviral Activities of Some 2,4,6-Trisubstituted 1,3,5-Triazines

We describe the synthesis and results of biological evaluation of newly designed 2,4,6-trisubstituted symmetrical 1,3,5-triazine (TAZ) derivatives. Among the tested trisubstituted TAZ derivatives, some CS-symmetrical alkoxy-amino-substituted TAZ derivatives, including 7ggp and 6dpp, showed significa...

Full description

Saved in:
Bibliographic Details
Published inChemical & pharmaceutical bulletin Vol. 62; no. 10; pp. 1032 - 1040
Main Authors Mibu, Nobuko, Yokomizo, Kazumi, Koga, Airi, Honda, Miyuki, Mizokami, Kou, Fujii, Hiroyuki, Ota, Norimasa, Yuzuriha, Ai, Ishimaru, Kanji, Zhou, Jianrong, Miyata, Takeshi, Sumoto, Kunihiro
Format Journal Article
LanguageEnglish
Published TOKYO The Pharmaceutical Society of Japan 01.10.2014
Pharmaceutical Society of Japan
Pharmaceutical Soc Japan
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We describe the synthesis and results of biological evaluation of newly designed 2,4,6-trisubstituted symmetrical 1,3,5-triazine (TAZ) derivatives. Among the tested trisubstituted TAZ derivatives, some CS-symmetrical alkoxy-amino-substituted TAZ derivatives, including 7ggp and 6dpp, showed significant antiviral activity against herpes simplex virus type 1 (HSV-1). The compound with the highest level of antiviral activity was C3-symmetrical trialkoxy-TAZ derivative 4bbb, which showed a considerably high selectivity index (IC50/EC50=256.6). The structure–activity relationships for anti-HSV-1 activity of the tested 2,4,6-trisubstituted TAZ derivatives are also described.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0009-2363
1347-5223
DOI:10.1248/cpb.c14-00421